Author:
McLucas Bruce,Vail Eric,Chua Katherine Jane,Walt Gabriel
Abstract
Essentially all cervical dysplasia is caused by human papilloma virus (HPV). Three HPV vaccines have been available, with Gardasil-9 being the most recently approved in the USA. Gardasil-9 covers high-risk HPV strains 16, 18, 31, 33, 45, 52 and 58 as well as low-risk strains 6 and 11. A 33-year-old woman (Gravida 2, Para 2) received Gardasil in 2006. Subsequently, her pap smear revealed low grade squamous intraepithelial lesion. Cervical biopsies performed in 2015 and 2016 revealed cervical intraepithelial neoplasia grade 1 (CIN 1). She underwent loop electrosurgical excision procedure for persistent CIN 1, which demonstrated CIN 3. Genotyping revealed HPV type 56 infection. The advancement of Gardasil-9 vaccine only offers 90% protection to patients against HPV-related disease. Lay literature may mislead patients to think they have no risk of HPV infection.
Reference8 articles.
1. Gardasil-9: A global survey of projected efficacy;Zhai;Antiviral Res,2016
2. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing;Schiffman;Cancer,2007
3. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine;Villa;Int J Infect Dis,2007
4. Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program;Baldur-Felskov;Cancer Causes Control,2014
5. Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years;Yoshikawa;Cancer Sci,2013
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献